A utilização de finasterida e minoxidil no tratamento da alopécia androgenética

Abstract

Androgenetic alopecia or male pattern baldness is a physiological alteration that affects individuals genetically predisposed to hair loss. This process is the result of stimulation of the hair follicles by male hormones whose onset occurs in adolescence. As it reaches the scalp of patients with a genetic tendency to baldness, the action of an enzyme on testosterone 5-alpha reductase, which is transformed into dihydrotestosterone (DHT), acts on the hair follicles and causes Continuous hair loss. Thus, the general objective of this article is to present the characteristics of finasteride and minoxidil in the treatment of Androgenetic Alopecia, as well as to highlight doubts about possible side effects, and at the same time to demonstrate the efficacy indices of these drugs. For the development of this, the bibliographic model was adopted, since all types of research in any area of knowledge presuppose and require prior bibliographic research, either for the survey of the situation in question, or for the theoretical basis or to justify the limits And contributions of the research itself. The results showed that both finasteride and minoxidil are the main drugs used for Androgenetic Alopecia, obtaining better results when used in an associated way.